Volume 39 Issue 1
Jan.  2023
Turn off MathJax
Article Contents
Yao MY,Zhang N,Zhang Q,et al.Effects of interleukin-4-modified gold nanozymes on the full-thickness skin defects in diabetic mice[J].Chin J Burns Wounds,2023,39(1):15-24.DOI: 10.3760/cma.j.cn501225-20220630-00275.
Citation: Yao MY,Zhang N,Zhang Q,et al.Effects of interleukin-4-modified gold nanozymes on the full-thickness skin defects in diabetic mice[J].Chin J Burns Wounds,2023,39(1):15-24.DOI: 10.3760/cma.j.cn501225-20220630-00275.

Effects of interleukin-4-modified gold nanozymes on the full-thickness skin defects in diabetic mice

doi: 10.3760/cma.j.cn501225-20220630-00275
Funds:

Youth Science Foundation Project of National Natural Science Foundation of China 82002044

Funds for International Cooperation and Exchange of the National Natural Science Foundation of China 81920108022

More Information
  • Corresponding author: Luo Gaoxing, Email: logxw@tmmu.edu.cn
  • Received Date: 2022-06-30
  •   Objective  To investigate the effects and mechanism of interleukin-4-modified gold nanoparticle (IL-4-AuNP) on the wound healing of full-thickness skin defects in diabetic mice.  Methods  Experimental research methods were adopted. Gold nanoparticle (AuNP) and IL-4-AuNP were synthesized by improving the methods described in published literature. The morphology of those two particles were photographed by transmission electron microscopy, and their particle sizes were calculated. The surface potential and hydration particle size of the two particles were detected by nanoparticle potentiometer and particle size analyzer, respectively. The clearance rate of IL-4-AuNP to hydrogen peroxide and superoxide anion was measured by hydrogen peroxide and superoxide anion kits, respectively. Mouse fibroblast line 3T3 cells were used and divided into the following groups by the random number table (the same below): blank control group, hydrogen peroxide alone group treated with hydrogen peroxide only, hydrogen peroxide+IL-4-AuNP group treated with IL-4-AuNP for 0.5 h and then treated with hydrogen peroxide. After 24 h of culture, the reactive oxygen species (ROS) levels of cells were detected by immunofluorescence method; cell count kit 8 was used to detect relative cell survival rate. The macrophage Raw264.7 mouse cells were then used and divided into blank control group and IL-4-AuNP group that treated with IL-4-AuNP. After 24 h of culture, the expression of arginase 1 (Arg-1) in cells was observed by immunofluorescence method. Twelve male BALB/c mice (mouse age, sex, and strain, the same below) aged 8 to 10 weeks were divided into IL-4-AuNP group and blank control group, treated accordingly. On the 16th day of treatment, whole blood samples were collected from mice for analysis of white blood cell count (WBC), red blood cell count (RBC), hemoglobin level, or platelet count and the level of aspartate aminotransferase (AST), alanine transaminase (ALT), urea, or creatinine. The inflammation, bleeding, or necrosis in the heart, liver, spleen, lung, and kidney tissue of mice were detected by hematoxylin-eosin (HE). Another 36 mice were selected to make diabetic model, and the full-thickness skin defect wounds were made on the back of these mice. The wounds were divided into blank control group, AuNP alone group, and IL-4-AuNP group, with 12 mice in each group, and treated accordingly. On the 0 (immediately), 4th, 9th, and 15th day of treatment, the wound condition was observed and the wound area was calculated. On the 9th day of treatment, HE staining was used to detect the length of neonatal epithelium and the thickness of granulation tissue in the wound. On the 15th day of treatment, immunofluorescence method was used to detect ROS level and the number of Arg-1 positive cells in the wound tissue. The number of samples was 6 in all cases. Data were statistically analyzed with independent sample t test, corrected t test, Tukey test, or Dunnett T3 test.  Results  The size of prepared AuNP and IL-4-AuNP were uniform. The particle size, surface potential, and hydration particle size of AuNP and IL-4-AuNP were (13.0±2.1) and (13.9±2.5) nm, (-45.8±3.2) and (-20.3±2.2) mV, (14±3) and (16±4) nm, respectively. For IL-4-AuNP, the clearance rate to hydrogen peroxide and superoxide anion were (69±4)% and (52±5)%, respectively. After 24 h of culture, the ROS level of 3T3 in hydrogen peroxide alone group was significantly higher than that in blank control group (q=26.12, P<0.05); the ROS level of hydrogen peroxide+IL-4-AuNP group was significantly lower than that in hydrogen peroxide alone group (q=25.12, P<0.05) and close to that in blank control group (P>0.05). After 24 h of culture, the relative survival rate of 3T3 cells in hydrogen peroxide+IL-4-AuNP group was significantly higher than that in hydrogen peroxide alone group (t=51.44, P<0.05). After 24 h of culture, Arg-1 expression of Raw264.7 cells in IL-4-AuNP group was significantly higher than that in blank control group (t'=8.83, P<0.05).On the 16th day of treatment, there were no significant statistically differences in WBC, RBC, hemoglobin level, or platelet count and the level of AST, ALT, urea, or creatinine of mice between blank control group and IL-4-AuNP group (P>0.05). No obvious inflammation, bleeding or necrosis was observed in the heart, liver, spleen, lung, and kidney of important organs in IL-4-AuNP group, and no significant changes were observed compared with blank control group. On the 0 and 4th day of treatment, the wound area of diabetic mice in blank control group, AuNP alone group, and IL-4-AuNP group had no significant difference (P>0.05). On the 9th day of treatment, the wound areas both in AuNP alone group and IL-4-AuNP group were significantly smaller than that in blank control group (with q values of 9.45 and 14.87, respectively, P<0.05), the wound area in IL-4-AuNP group was significantly smaller than that in AuNP alone group (q=5.42, P<0.05). On the 15th day of treatment, the wound areas both in AuNP alone group and IL-4-AuNP group were significantly smaller than that in blank control group (with q values of 4.84 and 20.64, respectively, P<0.05), the wound area in IL-4-AuNP group was significantly smaller than that in AuNP alone group (q=15.80, P<0.05); moreover, inflammations such as redness and swelling were significantly reduced in IL-4-AuNP group compared with the other two groups. On the 9th day of treatment, compared with blank control group and AuNP alone group, the length of neonatal epithelium in the wound of diabetic mice in IL-4-AuNP group was significantly longer (all P<0.05), and the thickness of the granulation tissue in the wound was significantly increased (with q values of 11.33 and 9.65, respectively, all P<0.05). On the 15th day of treatment, compared with blank control group, ROS levels in wound tissue of diabetic mice in AuNP alone group and IL-4-AuNP group were significantly decreased (P<0.05). On the 15th day of treatment, the number of Arg-1 positive cells in the wounds of diabetic mice in IL-4-AuNP group was significantly more than that in blank control group and AuNP alone group, respectively (all P<0.05).  Conclusions  IL-4-AuNP is safe in vivo, and can improve the oxidative microenvironment by removing ROS and induce macrophage polarization towards M2 phenotype, thus promote efficient diabetic wound healing and regeneration of full-thickness skin defects in diabetic mice.

     

  • loading
  • [1]
    SaeediP, PetersohnI, SalpeaP, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition[J].Diabetes Res Clin Pract,2019,157:107843.DOI: 10.1016/j.diabres.2019.107843.
    [2]
    ArmstrongDG, BoultonAJM, BusSA. Diabetic foot ulcers and their recurrence[J].N Engl J Med, 2017,376(24):2367-2375.DOI: 10.1056/NEJMra1615439.
    [3]
    SchaperNC, Van NettenJJ, ApelqvistJ, et al. Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents[J].Diabetes Res Clin Pract,2017,124:84-92.DOI: 10.1016/j.diabres.2016.12.007.
    [4]
    SunkariVG, LindF, BotusanIR, et al. Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice[J].Wound Repair Regen, 2015,23(1):98-103.DOI: 10.1111/wrr.12253.
    [5]
    EverettE, MathioudakisN. Update on management of diabetic foot ulcers[J].Ann N Y Acad Sci,2018,1411(1):153-165.DOI: 10.1111/nyas.13569.
    [6]
    HingoraniA, LaMuragliaGM, HenkeP, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine[J].J Vasc Surg,2016,63(2 Suppl):S3-21.DOI: 10.1016/j.jvs.2015.10.003.
    [7]
    WuH, LiF, ShaoW, et al. Promoting angiogenesis in oxidative diabetic wound microenvironment using a nanozyme-reinforced self-protecting hydrogel[J].ACS Cent Sci,2019,5(3):477-485.DOI: 10.1021/acscentsci.8b00850.
    [8]
    MouraLI, DiasAM, CarvalhoE, et al. Recent advances on the development of wound dressings for diabetic foot ulcer treatment--a review[J].Acta Biomater,2013,9(7):7093-7114.DOI: 10.1016/j.actbio.2013.03.033.
    [9]
    VeithAP, HendersonK, SpencerA, et al. Therapeutic strategies for enhancing angiogenesis in wound healing[J].Adv Drug Delivery Rev,2019,146:97-125.DOI: 10.1016/j.addr.2018.09.010.
    [10]
    LaroucheJ, SheoranS, MaruyamaK, et al. Immune regulation of skin wound healing: mechanisms and novel therapeutic targets[J].Adv Wound Care,2018(New Rochelle),7(7):209-231.DOI: 10.1089/wound.2017.0761.
    [11]
    BoniakowskiAE, KimballAS, JacobsBN, et al. Macrophage-mediated inflammation in normal and diabetic wound healing[J].J Immunol,2017,199(1):17-24.DOI: 10.4049/jimmunol.1700223.
    [12]
    KimH, WangSY, KwakG, et al. Exosome-guided phenotypic switch of M1 to M2 macrophages for cutaneous wound healing[J].Adv Sci(Weinh),2019,6(20):1900513.DOI: 10.1002/advs.201900513.
    [13]
    WuJ, ChenA, ZhouY, et al. Novel H2S-releasing hydrogel for wound repair via in situ polarization of M2 macrophages[J].Biomaterials,2019,222:119398.DOI: 10.1016/j.biomaterials.2019.119398.
    [14]
    GanJ, LiuC, LiH, et al. Accelerated wound healing in diabetes by reprogramming the macrophages with particle-induced clustering of the mannose receptors[J].Biomaterials,2019,219:119340.DOI: 10.1016/j.biomaterials.2019.119340.
    [15]
    EmingSA, MartinP, Tomic-CanicM. Wound repair and regeneration: mechanisms, signaling, and translation[J].Sci Transl Med,2014,6(265):265sr6.DOI: 10.1126/scitranslmed.3009337.
    [16]
    WuH, LiF, ShaoW, et al. Promoting angiogenesis in oxidative diabetic wound microenvironment using a nanozyme-reinforced self-protecting hydrogel[J].ACS Cent Sci,2019,5(3):477-485.DOI: 10.1021/acscentsci.8b00850.
    [17]
    MittalM, SiddiquiMR, TranK, et al. ROS in inflammation and tissue injury[J].Antioxid Redox Signal,2014,20(7):1126-1167.DOI: 10.1089/ars.2012.5149.
    [18]
    ManeaF, HouillonFB, PasquatoL, et al. Nanozymes: gold-nanoparticle-based transphosphorylation catalysts[J].Angew Chem Int Ed Engl,2004,43(45):6165-6169.DOI: 10.1002/anie.200460649.
    [19]
    YangH, FungSY, XuSY, et al. Amino acid-dependent attenuation of toll-like receptor signaling by peptide-gold nanoparticle hybrids[J].ACS Nano,2015,9(7):6774-6784.DOI: 10.1021/nn505634h.
    [20]
    StorhoffJJ, ElghanianR, MucicRC, et al. One-pot colorimetric differentiation of polynucleotides with single base imperfections using gold nanoparticle probes[J].J Am ChemSoc,1998,120(9):1959-1964.DOI: 10.1021/ja972332i.
    [21]
    WangL, ZhangH, SunL, et al. Manipulation of macrophage polarization by peptide-coated gold nanoparticles and its protective effects on acute lung injury[J].J Nanobiotechnology,2020,18(1):38.DOI: 10.1186/s12951-020-00593-7.
    [22]
    LiYJ, LuoLJ, HarrounSG, et al. Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease[J].Nanoscale,2019,11(12):5580-5594.DOI: 10.1039/c9nr00376b.
    [23]
    LuY, LiH, WangJ, et al. Engineering bacteria-activated multifunctionalized hydrogel for promoting diabetic wound healing[J].Adv Funct Mater,2021,31(48):2105749.DOI: 10.1002/adfm.202105749.
    [24]
    ChenH, ChengY, TianJ, et al. Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetes[J].Sci Adv,2020,6(20):eaba4311.DOI: 10.1126/sciadv.aba4311.
    [25]
    XiaS, WengT, JinR, et al. Curcumin-incorporated 3D bioprinting gelatin methacryloyl hydrogel reduces reactive oxygen species-induced adipose-derived stem cell apoptosis and improves implanting survival in diabetic wounds[J/OL]. Burns Trauma,2022,10:tkac001[2022-06-30].https://pubmed.ncbi.nlm.nih.gov/35291229/.DOI: 10.1093/burnst/tkac001.
    [26]
    EmingSA, WynnTA, MartinP. Inflammation and metabolism in tissue repair and regeneration[J].Science,2017,356(6342):1026-1030.DOI: 10.1126/science.aam7928.
    [27]
    LouiselleAE, NiemiecSM, ZgheibC, et al. Macrophage polarization and diabetic wound healing[J].Transl Res,2021,236:109-116.DOI: 10.1016/j.trsl.2021.05.006.
    [28]
    YouJ, ZhangG, LiC. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release[J].ACS Nano,2010,4(2):1033-1041.DOI: 10.1021/nn901181c.
    [29]
    Lou-FrancoJ, DasB, ElliottC, et al. Gold nanozymes: from concept to biomedical applications[J].Nanomicro Lett,2020,13(1):10.DOI: 10.1007/s40820-020-00532-z.
    [30]
    LiuX, LiuJ, ZhaoS, et al. Interleukin-4 is essential for microglia/macrophage M2 polarization and long-term recovery after cerebral ischemia[J].Stroke,2016,47(2):498-504.DOI: 10.1161/STROKEAHA.115.012079.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(9)  / Tables(2)

    Article Metrics

    Article views (3810) PDF downloads(50) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return